NanoParticle Ontology for cancer nanotechnology research

Data generated from cancer nanotechnology research are so diverse and large in volume that it is difficult to share and efficiently use them without informatics tools. In particular, ontologies that provide a unifying knowledge framework for annotating the data are required to facilitate the semantic integration, knowledge-based searching, unambiguous interpretation, mining and inferencing of the data using informatics methods. In this paper, we discuss the design and development of NanoParticle Ontology (NPO), which is developed within the framework of the Basic Formal Ontology (BFO), and implemented in the Ontology Web Language (OWL) using well-defined ontology design principles. The NPO was developed to represent knowledge underlying the preparation, chemical composition, and characterization of nanomaterials involved in cancer research. Public releases of the NPO are available through BioPortal website, maintained by the National Center for Biomedical Ontology. Mechanisms for editorial and governance processes are being developed for the maintenance, review, and growth of the NPO.

[1]  Stefan Schulz,et al.  Biomedical ontologies: What part-of is and isn't , 2006, J. Biomed. Informatics.

[2]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[3]  Aravind Subramanian,et al.  Perturbational profiling of nanomaterial biologic activity , 2008, Proceedings of the National Academy of Sciences.

[4]  Tero Aittokallio,et al.  Improving missing value estimation in microarray data with gene ontology , 2006, Bioinform..

[5]  A. Rector,et al.  Relations in biomedical ontologies , 2005, Genome Biology.

[6]  Carole A. Goble,et al.  Ontology-based Knowledge Representation for Bioinformatics , 2000, Briefings Bioinform..

[7]  Artem Cherkasov,et al.  The use of Gene Ontology terms for predicting highly-connected 'hub' nodes in protein-protein interaction networks , 2008, BMC Systems Biology.

[8]  Ralph Weissleder,et al.  Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. , 2002, Bioconjugate chemistry.

[9]  James R Baker,et al.  Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. , 2007, Small.

[10]  Alan L. Rector,et al.  Modularisation of domain ontologies implemented in description logics and related formalisms including OWL , 2003, K-CAP '03.

[11]  Michel Dumontier,et al.  Describing Chemical Functional Groups in OWL-DL for the Classification of Chemical Compounds , 2007, OWLED.

[12]  Mauro Ferrari,et al.  The mathematical engines of nanomedicine. , 2008, Small.

[13]  John R. Gilbertson,et al.  Microarray Data Mining Using Gene Ontology , 2004, MedInfo.

[14]  Thomas R. Gruber,et al.  A translation approach to portable ontology specifications , 1993 .

[15]  Lawrence H. Smith,et al.  Retrieving definitional content for ontology development , 2004, Comput. Biol. Chem..

[16]  Michael Darsow,et al.  ChEBI: a database and ontology for chemical entities of biological interest , 2007, Nucleic Acids Res..

[17]  Daniel L. Rubin,et al.  Biomedical ontologies: a functional perspective , 2007, Briefings Bioinform..

[18]  Andrew D. Spear.  Ontology for the Twenty First Century: An Introduction with Recommendations , 2006 .

[19]  Stuart J. Nelson,et al.  The MeSH Translation Maintenance System: Structure, Interface Design, and Implementation , 2004, MedInfo.

[20]  Mark S. Tuttle,et al.  NCI Thesaurus: Using Science-Based Terminology to Integrate Cancer Research Results , 2004, MedInfo.

[21]  Michael Hawkins,et al.  Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Kazunori Kataoka,et al.  Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. , 2005, Molecular bioSystems.

[23]  A. Maitra,et al.  Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. , 2000, International journal of pharmaceutics.

[24]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[25]  Carol Friedman,et al.  Information theory applied to the sparse gene ontology annotation network to predict novel gene function , 2007, ISMB/ECCB.

[26]  N. F. Noy,et al.  Ontology Development 101: A Guide to Creating Your First Ontology , 2001 .

[27]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[28]  Christopher G. Chute,et al.  BioPortal: ontologies and integrated data resources at the click of a mouse , 2009, Nucleic Acids Res..

[29]  S. Nie,et al.  Nanotechnology applications in cancer. , 2007, Annual review of biomedical engineering.

[30]  Yarden Katz,et al.  Pellet: A practical OWL-DL reasoner , 2007, J. Web Semant..

[31]  Samson W. Tu,et al.  Protégé-2000: An Open-Source Ontology-Development and Knowledge-Acquisition Environment: AMIA 2003 Open Source Expo , 2003, AMIA.

[32]  Christopher G Chute,et al.  National Center for Biomedical Ontology: advancing biomedicine through structured organization of scientific knowledge. , 2006, Omics : a journal of integrative biology.

[33]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[34]  J. Blake.  Bio-ontologies—fast and furious , 2004, Nature Biotechnology.

[35]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[36]  M A Musen,et al.  Dimensions of knowledge sharing and reuse. , 1992, Computers and biomedical research, an international journal.